All stock lists
Sabra Health Care REIT, Inc. (NASDAQ:SBRA)
US · Delayed Price · Currency is USD
Real Estate · REIT - Healthcare Facilities
19.68+0.13 (+0.64%)
Insider Score
––Not scored
SBRA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SBRA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 235.87 M | 221.75 M | 211.90 M | 190.04 M | 189.15 M | 183.54 M |
| Revenue Growth (YoY) | 24.70 % | 20.82 % | 16.21 % | 6.76 % | 7.39 % | 10.07 % |
| Cost of Revenue | 92.27 M | 85.64 M | 80.42 M | 69.65 M | 61.10 M | 59.93 M |
| Gross Profit | 143.59 M | 136.11 M | 131.49 M | 120.38 M | 128.05 M | 123.61 M |
| SG&A Expense | 16.82 M | 14.86 M | 15.91 M | 12.56 M | 12.51 M | 12.73 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 175.64 M | 96.63 M | 66.91 M | 60.83 M | 56.10 M | 56.22 M |
| Operating Income | -32.05 M | 39.48 M | 64.58 M | 59.55 M | 71.95 M | 67.39 M |
| Pretax Income | -24.57 M | 39.43 M | 27.64 M | 22.95 M | 66.04 M | 40.72 M |
| Tax Provision | 678.00 K | 526.00 K | 491.00 K | 436.00 K | 497.00 K | 413.00 K |
| Net Income | -25.20 M | 40.88 M | 27.23 M | 22.54 M | 65.54 M | 40.30 M |
| EPS (Basic) | -0.10 | 0.16 | 0.11 | 0.09 | 0.28 | 0.17 |
| EPS (Diluted) | -0.10 | 0.16 | 0.11 | 0.09 | 0.27 | 0.17 |
| Shares Outstanding | 252.27 M | 252.14 M | 249.38 M | 239.90 M | 237.98 M | 237.89 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
